nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP3A4—Thiotepa—sarcoma	0.118	0.178	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—sarcoma	0.0944	0.143	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—sarcoma	0.0845	0.128	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—sarcoma	0.0787	0.119	CbGbCtD
Trimethoprim—ABCB1—Vincristine—sarcoma	0.0582	0.0878	CbGbCtD
Trimethoprim—ABCB1—Etoposide—sarcoma	0.0533	0.0804	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—sarcoma	0.0506	0.0764	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—sarcoma	0.0364	0.0549	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—sarcoma	0.0348	0.0526	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—sarcoma	0.0319	0.0482	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—sarcoma	0.0218	0.0329	CbGbCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—sarcoma	0.00358	0.372	CbGdCrCtD
Trimethoprim—TYMS—Podofilox—Etoposide—sarcoma	0.00358	0.372	CbGdCrCtD
Trimethoprim—DHFR—myometrium—sarcoma	0.003	0.0503	CbGeAlD
Trimethoprim—DHFR—embryo—sarcoma	0.00289	0.0484	CbGeAlD
Trimethoprim—DHFR—seminal vesicle—sarcoma	0.00271	0.0454	CbGeAlD
Trimethoprim—TYMS—hematopoietic system—sarcoma	0.0026	0.0436	CbGeAlD
Trimethoprim—DHFR—hematopoietic system—sarcoma	0.00258	0.0432	CbGeAlD
Trimethoprim—TYMS—connective tissue—sarcoma	0.0025	0.042	CbGeAlD
Trimethoprim—DHFR—connective tissue—sarcoma	0.00248	0.0416	CbGeAlD
Trimethoprim—TYMS—Vinblastine—Vincristine—sarcoma	0.00246	0.256	CbGdCrCtD
Trimethoprim—TYMS—smooth muscle tissue—sarcoma	0.00229	0.0384	CbGeAlD
Trimethoprim—TYMS—skin of body—sarcoma	0.00226	0.0379	CbGeAlD
Trimethoprim—CYP2C8—mammary gland—sarcoma	0.0021	0.0352	CbGeAlD
Trimethoprim—DHFR—cardiac atrium—sarcoma	0.00196	0.0328	CbGeAlD
Trimethoprim—DHFR—uterus—sarcoma	0.00195	0.0326	CbGeAlD
Trimethoprim—CYP2C9—mammary gland—sarcoma	0.00186	0.0313	CbGeAlD
Trimethoprim—TYMS—lymphoid tissue—sarcoma	0.00183	0.0307	CbGeAlD
Trimethoprim—DHFR—lymphoid tissue—sarcoma	0.00181	0.0304	CbGeAlD
Trimethoprim—TYMS—tendon—sarcoma	0.00172	0.0289	CbGeAlD
Trimethoprim—DHFR—tendon—sarcoma	0.0017	0.0286	CbGeAlD
Trimethoprim—TYMS—bone marrow—sarcoma	0.00167	0.028	CbGeAlD
Trimethoprim—DHFR—bone marrow—sarcoma	0.00165	0.0277	CbGeAlD
Trimethoprim—TYMS—testis—sarcoma	0.00143	0.0239	CbGeAlD
Trimethoprim—DHFR—testis—sarcoma	0.00141	0.0237	CbGeAlD
Trimethoprim—TYMS—liver—sarcoma	0.00135	0.0226	CbGeAlD
Trimethoprim—DHFR—liver—sarcoma	0.00133	0.0224	CbGeAlD
Trimethoprim—CYP2C8—hematopoietic system—sarcoma	0.00128	0.0214	CbGeAlD
Trimethoprim—CYP2C9—hematopoietic system—sarcoma	0.00114	0.019	CbGeAlD
Trimethoprim—TYMS—lymph node—sarcoma	0.00103	0.0173	CbGeAlD
Trimethoprim—DHFR—lymph node—sarcoma	0.00102	0.0172	CbGeAlD
Trimethoprim—CYP3A4—hematopoietic system—sarcoma	0.000866	0.0145	CbGeAlD
Trimethoprim—Confusional state—Mitoxantrone—sarcoma	0.000736	0.00274	CcSEcCtD
Trimethoprim—Nervous system disorder—Vincristine—sarcoma	0.000735	0.00274	CcSEcCtD
Trimethoprim—Decreased appetite—Thiotepa—sarcoma	0.000735	0.00274	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Epirubicin—sarcoma	0.000734	0.00274	CcSEcCtD
Trimethoprim—Thrombocytopenia—Vincristine—sarcoma	0.000734	0.00274	CcSEcCtD
Trimethoprim—Anaphylactic shock—Mitoxantrone—sarcoma	0.00073	0.00272	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Thiotepa—sarcoma	0.00073	0.00272	CcSEcCtD
Trimethoprim—Photosensitivity—Doxorubicin—sarcoma	0.00073	0.00272	CcSEcCtD
Trimethoprim—Decreased appetite—Dactinomycin—sarcoma	0.000729	0.00272	CcSEcCtD
Trimethoprim—Renal impairment—Epirubicin—sarcoma	0.000728	0.00271	CcSEcCtD
Trimethoprim—Dermatitis bullous—Epirubicin—sarcoma	0.000725	0.0027	CcSEcCtD
Trimethoprim—Constipation—Thiotepa—sarcoma	0.000723	0.0027	CcSEcCtD
Trimethoprim—Purpura—Epirubicin—sarcoma	0.000719	0.00268	CcSEcCtD
Trimethoprim—Shock—Mitoxantrone—sarcoma	0.000718	0.00268	CcSEcCtD
Trimethoprim—Vascular purpura—Doxorubicin—sarcoma	0.000716	0.00267	CcSEcCtD
Trimethoprim—Thrombocytopenia—Mitoxantrone—sarcoma	0.000715	0.00267	CcSEcCtD
Trimethoprim—Anorexia—Vincristine—sarcoma	0.000715	0.00266	CcSEcCtD
Trimethoprim—ABCB1—myometrium—sarcoma	0.000714	0.012	CbGeAlD
Trimethoprim—Hypoglycaemia—Epirubicin—sarcoma	0.00071	0.00265	CcSEcCtD
Trimethoprim—Skin disorder—Mitoxantrone—sarcoma	0.000709	0.00264	CcSEcCtD
Trimethoprim—Lethargy—Epirubicin—sarcoma	0.000707	0.00264	CcSEcCtD
Trimethoprim—CYP2C8—testis—sarcoma	0.000701	0.0117	CbGeAlD
Trimethoprim—Feeling abnormal—Thiotepa—sarcoma	0.000697	0.0026	CcSEcCtD
Trimethoprim—Anorexia—Mitoxantrone—sarcoma	0.000696	0.00259	CcSEcCtD
Trimethoprim—Hyponatraemia—Epirubicin—sarcoma	0.000695	0.00259	CcSEcCtD
Trimethoprim—Feeling abnormal—Dactinomycin—sarcoma	0.000691	0.00258	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Thiotepa—sarcoma	0.000691	0.00258	CcSEcCtD
Trimethoprim—ABCB1—embryo—sarcoma	0.000687	0.0115	CbGeAlD
Trimethoprim—Gastrointestinal pain—Dactinomycin—sarcoma	0.000686	0.00256	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vincristine—sarcoma	0.000683	0.00255	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000679	0.00253	CcSEcCtD
Trimethoprim—Insomnia—Vincristine—sarcoma	0.000678	0.00253	CcSEcCtD
Trimethoprim—Renal impairment—Doxorubicin—sarcoma	0.000673	0.00251	CcSEcCtD
Trimethoprim—Urticaria—Thiotepa—sarcoma	0.000672	0.0025	CcSEcCtD
Trimethoprim—Dermatitis bullous—Doxorubicin—sarcoma	0.00067	0.0025	CcSEcCtD
Trimethoprim—Vertigo—Etoposide—sarcoma	0.000668	0.00249	CcSEcCtD
Trimethoprim—Abdominal pain—Thiotepa—sarcoma	0.000668	0.00249	CcSEcCtD
Trimethoprim—Body temperature increased—Thiotepa—sarcoma	0.000668	0.00249	CcSEcCtD
Trimethoprim—Leukopenia—Etoposide—sarcoma	0.000666	0.00248	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000665	0.00248	CcSEcCtD
Trimethoprim—Purpura—Doxorubicin—sarcoma	0.000665	0.00248	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—sarcoma	0.000663	0.00247	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—sarcoma	0.000663	0.00247	CcSEcCtD
Trimethoprim—CYP2C8—liver—sarcoma	0.000662	0.0111	CbGeAlD
Trimethoprim—Hypoglycaemia—Doxorubicin—sarcoma	0.000657	0.00245	CcSEcCtD
Trimethoprim—Loss of consciousness—Etoposide—sarcoma	0.000654	0.00244	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—sarcoma	0.000654	0.00244	CcSEcCtD
Trimethoprim—Decreased appetite—Vincristine—sarcoma	0.000652	0.00243	CcSEcCtD
Trimethoprim—Ataxia—Epirubicin—sarcoma	0.000651	0.00243	CcSEcCtD
Trimethoprim—Dyspnoea—Mitoxantrone—sarcoma	0.000651	0.00243	CcSEcCtD
Trimethoprim—Cough—Etoposide—sarcoma	0.000649	0.00242	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vincristine—sarcoma	0.000647	0.00241	CcSEcCtD
Trimethoprim—ABCB1—seminal vesicle—sarcoma	0.000645	0.0108	CbGeAlD
Trimethoprim—Convulsion—Etoposide—sarcoma	0.000645	0.0024	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—sarcoma	0.000643	0.0024	CcSEcCtD
Trimethoprim—Dyspepsia—Mitoxantrone—sarcoma	0.000643	0.0024	CcSEcCtD
Trimethoprim—Constipation—Vincristine—sarcoma	0.000641	0.00239	CcSEcCtD
Trimethoprim—Decreased appetite—Mitoxantrone—sarcoma	0.000635	0.00237	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000629	0.00235	CcSEcCtD
Trimethoprim—Constipation—Mitoxantrone—sarcoma	0.000624	0.00233	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000624	0.00233	CcSEcCtD
Trimethoprim—Hypersensitivity—Thiotepa—sarcoma	0.000623	0.00232	CcSEcCtD
Trimethoprim—Hypersensitivity—Dactinomycin—sarcoma	0.000618	0.00231	CcSEcCtD
Trimethoprim—ABCB1—hematopoietic system—sarcoma	0.000613	0.0103	CbGeAlD
Trimethoprim—Gastrointestinal pain—Vincristine—sarcoma	0.000613	0.00229	CcSEcCtD
Trimethoprim—Confusional state—Etoposide—sarcoma	0.000612	0.00228	CcSEcCtD
Trimethoprim—Anaphylactic shock—Etoposide—sarcoma	0.000607	0.00226	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—sarcoma	0.000603	0.00225	CcSEcCtD
Trimethoprim—Feeling abnormal—Mitoxantrone—sarcoma	0.000602	0.00224	CcSEcCtD
Trimethoprim—Pruritus—Thiotepa—sarcoma	0.000598	0.00223	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000597	0.00223	CcSEcCtD
Trimethoprim—Thrombocytopenia—Etoposide—sarcoma	0.000595	0.00222	CcSEcCtD
Trimethoprim—Eosinophilia—Epirubicin—sarcoma	0.000593	0.00221	CcSEcCtD
Trimethoprim—Abdominal pain—Vincristine—sarcoma	0.000593	0.00221	CcSEcCtD
Trimethoprim—Body temperature increased—Vincristine—sarcoma	0.000593	0.00221	CcSEcCtD
Trimethoprim—Skin disorder—Etoposide—sarcoma	0.00059	0.0022	CcSEcCtD
Trimethoprim—CYP2C9—liver—sarcoma	0.000588	0.00986	CbGeAlD
Trimethoprim—Pancreatitis—Epirubicin—sarcoma	0.000587	0.00219	CcSEcCtD
Trimethoprim—Urticaria—Mitoxantrone—sarcoma	0.00058	0.00216	CcSEcCtD
Trimethoprim—Anorexia—Etoposide—sarcoma	0.000579	0.00216	CcSEcCtD
Trimethoprim—Diarrhoea—Thiotepa—sarcoma	0.000578	0.00216	CcSEcCtD
Trimethoprim—Body temperature increased—Mitoxantrone—sarcoma	0.000577	0.00215	CcSEcCtD
Trimethoprim—Abdominal pain—Mitoxantrone—sarcoma	0.000577	0.00215	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000577	0.00215	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—sarcoma	0.000574	0.00214	CcSEcCtD
Trimethoprim—Pancytopenia—Epirubicin—sarcoma	0.000568	0.00212	CcSEcCtD
Trimethoprim—Neutropenia—Epirubicin—sarcoma	0.00056	0.00209	CcSEcCtD
Trimethoprim—Dizziness—Thiotepa—sarcoma	0.000559	0.00208	CcSEcCtD
Trimethoprim—Hypersensitivity—Vincristine—sarcoma	0.000552	0.00206	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—sarcoma	0.000548	0.00204	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Epirubicin—sarcoma	0.000546	0.00204	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—sarcoma	0.000543	0.00202	CcSEcCtD
Trimethoprim—Dyspnoea—Etoposide—sarcoma	0.000541	0.00202	CcSEcCtD
Trimethoprim—Hypersensitivity—Mitoxantrone—sarcoma	0.000538	0.00201	CcSEcCtD
Trimethoprim—Vomiting—Thiotepa—sarcoma	0.000537	0.002	CcSEcCtD
Trimethoprim—Pneumonia—Epirubicin—sarcoma	0.000537	0.002	CcSEcCtD
Trimethoprim—Infestation NOS—Epirubicin—sarcoma	0.000534	0.00199	CcSEcCtD
Trimethoprim—Infestation—Epirubicin—sarcoma	0.000534	0.00199	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—sarcoma	0.000533	0.00199	CcSEcCtD
Trimethoprim—Rash—Thiotepa—sarcoma	0.000533	0.00199	CcSEcCtD
Trimethoprim—Dermatitis—Thiotepa—sarcoma	0.000532	0.00199	CcSEcCtD
Trimethoprim—Headache—Thiotepa—sarcoma	0.00053	0.00197	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000529	0.00197	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—sarcoma	0.000529	0.00197	CcSEcCtD
Trimethoprim—Decreased appetite—Etoposide—sarcoma	0.000528	0.00197	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—sarcoma	0.000526	0.00196	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—sarcoma	0.000525	0.00196	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Etoposide—sarcoma	0.000524	0.00195	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—sarcoma	0.000523	0.00195	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—sarcoma	0.00052	0.00194	CcSEcCtD
Trimethoprim—Constipation—Etoposide—sarcoma	0.000519	0.00194	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—sarcoma	0.000518	0.00193	CcSEcCtD
Trimethoprim—Diarrhoea—Vincristine—sarcoma	0.000513	0.00191	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—sarcoma	0.000509	0.0019	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—sarcoma	0.000506	0.00189	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—sarcoma	0.000505	0.00188	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—sarcoma	0.000503	0.00188	CcSEcCtD
Trimethoprim—Nausea—Thiotepa—sarcoma	0.000502	0.00187	CcSEcCtD
Trimethoprim—Feeling abnormal—Etoposide—sarcoma	0.0005	0.00187	CcSEcCtD
Trimethoprim—Diarrhoea—Mitoxantrone—sarcoma	0.000499	0.00186	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—sarcoma	0.000498	0.00186	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—sarcoma	0.000498	0.00186	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—sarcoma	0.000497	0.00185	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Etoposide—sarcoma	0.000497	0.00185	CcSEcCtD
Trimethoprim—Dizziness—Vincristine—sarcoma	0.000496	0.00185	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—sarcoma	0.000494	0.00184	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—sarcoma	0.000494	0.00184	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00049	0.00183	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—sarcoma	0.000485	0.00181	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—sarcoma	0.000484	0.00181	CcSEcCtD
Trimethoprim—Urticaria—Etoposide—sarcoma	0.000482	0.0018	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—sarcoma	0.000481	0.00179	CcSEcCtD
Trimethoprim—Body temperature increased—Etoposide—sarcoma	0.00048	0.00179	CcSEcCtD
Trimethoprim—Abdominal pain—Etoposide—sarcoma	0.00048	0.00179	CcSEcCtD
Trimethoprim—Vomiting—Vincristine—sarcoma	0.000477	0.00178	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—sarcoma	0.000473	0.00176	CcSEcCtD
Trimethoprim—Rash—Vincristine—sarcoma	0.000473	0.00176	CcSEcCtD
Trimethoprim—Dermatitis—Vincristine—sarcoma	0.000472	0.00176	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—sarcoma	0.000471	0.00176	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—sarcoma	0.000471	0.00176	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—sarcoma	0.00047	0.00175	CcSEcCtD
Trimethoprim—Headache—Vincristine—sarcoma	0.00047	0.00175	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—sarcoma	0.000467	0.00174	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—sarcoma	0.000466	0.00174	CcSEcCtD
Trimethoprim—Vomiting—Mitoxantrone—sarcoma	0.000464	0.00173	CcSEcCtD
Trimethoprim—ABCB1—uterus—sarcoma	0.000463	0.00776	CbGeAlD
Trimethoprim—Agranulocytosis—Doxorubicin—sarcoma	0.000461	0.00172	CcSEcCtD
Trimethoprim—Rash—Mitoxantrone—sarcoma	0.00046	0.00172	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—sarcoma	0.00046	0.00171	CcSEcCtD
Trimethoprim—Headache—Mitoxantrone—sarcoma	0.000457	0.00171	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—sarcoma	0.000453	0.00169	CcSEcCtD
Trimethoprim—CYP3A4—liver—sarcoma	0.000449	0.00752	CbGeAlD
Trimethoprim—Eye disorder—Epirubicin—sarcoma	0.000448	0.00167	CcSEcCtD
Trimethoprim—Hypersensitivity—Etoposide—sarcoma	0.000447	0.00167	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—sarcoma	0.000447	0.00167	CcSEcCtD
Trimethoprim—Nausea—Vincristine—sarcoma	0.000445	0.00166	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—sarcoma	0.000438	0.00163	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—sarcoma	0.000436	0.00162	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—sarcoma	0.000435	0.00162	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—sarcoma	0.000434	0.00162	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—sarcoma	0.000433	0.00161	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—sarcoma	0.000432	0.00161	CcSEcCtD
Trimethoprim—ABCB1—lymphoid tissue—sarcoma	0.000432	0.00724	CbGeAlD
Trimethoprim—Pruritus—Etoposide—sarcoma	0.00043	0.0016	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—sarcoma	0.00042	0.00157	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—sarcoma	0.000419	0.00156	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—sarcoma	0.000417	0.00156	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—sarcoma	0.000417	0.00156	CcSEcCtD
Trimethoprim—Diarrhoea—Etoposide—sarcoma	0.000415	0.00155	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—sarcoma	0.000414	0.00154	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—sarcoma	0.000413	0.00154	CcSEcCtD
Trimethoprim—Dizziness—Etoposide—sarcoma	0.000402	0.0015	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—sarcoma	0.0004	0.00149	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—sarcoma	0.0004	0.00149	CcSEcCtD
Trimethoprim—ABCB1—bone marrow—sarcoma	0.000393	0.00659	CbGeAlD
Trimethoprim—Mental disorder—Doxorubicin—sarcoma	0.000388	0.00145	CcSEcCtD
Trimethoprim—Vomiting—Etoposide—sarcoma	0.000386	0.00144	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—sarcoma	0.000386	0.00144	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—sarcoma	0.000386	0.00144	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—sarcoma	0.000383	0.00143	CcSEcCtD
Trimethoprim—Rash—Etoposide—sarcoma	0.000383	0.00143	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—sarcoma	0.000383	0.00143	CcSEcCtD
Trimethoprim—Headache—Etoposide—sarcoma	0.00038	0.00142	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—sarcoma	0.000375	0.0014	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—sarcoma	0.000374	0.00139	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—sarcoma	0.000373	0.00139	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—sarcoma	0.000367	0.00137	CcSEcCtD
Trimethoprim—Cough—Epirubicin—sarcoma	0.000364	0.00136	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—sarcoma	0.000361	0.00135	CcSEcCtD
Trimethoprim—Nausea—Etoposide—sarcoma	0.000361	0.00135	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—sarcoma	0.000355	0.00132	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—sarcoma	0.000355	0.00132	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—sarcoma	0.000355	0.00132	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—sarcoma	0.000354	0.00132	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000353	0.00131	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—sarcoma	0.000347	0.00129	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—sarcoma	0.000346	0.00129	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—sarcoma	0.000345	0.00129	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—sarcoma	0.000343	0.00128	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—sarcoma	0.00034	0.00127	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—sarcoma	0.000339	0.00126	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—sarcoma	0.000337	0.00126	CcSEcCtD
Trimethoprim—ABCB1—testis—sarcoma	0.000336	0.00563	CbGeAlD
Trimethoprim—Shock—Epirubicin—sarcoma	0.000335	0.00125	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—sarcoma	0.000334	0.00125	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—sarcoma	0.000334	0.00124	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—sarcoma	0.000333	0.00124	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—sarcoma	0.000331	0.00123	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—sarcoma	0.000329	0.00123	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—sarcoma	0.000329	0.00123	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—sarcoma	0.000327	0.00122	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000326	0.00122	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—sarcoma	0.000324	0.00121	CcSEcCtD
Trimethoprim—ABCB1—liver—sarcoma	0.000318	0.00532	CbGeAlD
Trimethoprim—Confusional state—Doxorubicin—sarcoma	0.000318	0.00118	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—sarcoma	0.000315	0.00117	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00031	0.00116	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—sarcoma	0.00031	0.00116	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—sarcoma	0.000309	0.00115	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—sarcoma	0.000308	0.00115	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—sarcoma	0.000308	0.00115	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—sarcoma	0.000306	0.00114	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—sarcoma	0.000303	0.00113	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—sarcoma	0.0003	0.00112	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—sarcoma	0.0003	0.00112	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—sarcoma	0.000296	0.0011	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—sarcoma	0.000294	0.0011	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—sarcoma	0.000291	0.00109	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000287	0.00107	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—sarcoma	0.000285	0.00106	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—sarcoma	0.000281	0.00105	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—sarcoma	0.00028	0.00105	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—sarcoma	0.000278	0.00104	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—sarcoma	0.000277	0.00103	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—sarcoma	0.000274	0.00102	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000272	0.00101	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—sarcoma	0.00027	0.00101	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—sarcoma	0.000269	0.001	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—sarcoma	0.000269	0.001	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—sarcoma	0.000269	0.001	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—sarcoma	0.00026	0.000968	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—sarcoma	0.000258	0.00096	CcSEcCtD
Trimethoprim—Hypersensitivity—Epirubicin—sarcoma	0.000251	0.000935	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—sarcoma	0.00025	0.000933	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—sarcoma	0.000249	0.000928	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—sarcoma	0.000249	0.000928	CcSEcCtD
Trimethoprim—ABCB1—lymph node—sarcoma	0.000244	0.00408	CbGeAlD
Trimethoprim—Pruritus—Epirubicin—sarcoma	0.000241	0.000898	CcSEcCtD
Trimethoprim—Diarrhoea—Epirubicin—sarcoma	0.000233	0.000868	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—sarcoma	0.000232	0.000865	CcSEcCtD
Trimethoprim—Dizziness—Epirubicin—sarcoma	0.000225	0.000839	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—sarcoma	0.000223	0.000831	CcSEcCtD
Trimethoprim—Vomiting—Epirubicin—sarcoma	0.000216	0.000807	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—sarcoma	0.000215	0.000804	CcSEcCtD
Trimethoprim—Rash—Epirubicin—sarcoma	0.000215	0.0008	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—sarcoma	0.000214	0.0008	CcSEcCtD
Trimethoprim—Headache—Epirubicin—sarcoma	0.000213	0.000795	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—sarcoma	0.000208	0.000777	CcSEcCtD
Trimethoprim—Nausea—Epirubicin—sarcoma	0.000202	0.000754	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—sarcoma	0.0002	0.000747	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—sarcoma	0.000199	0.000741	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—sarcoma	0.000198	0.00074	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—sarcoma	0.000197	0.000736	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—sarcoma	0.000187	0.000698	CcSEcCtD
